Fig. 7
Hepatic sox17 and sox32 expression in wnt2bb mutant and Wnt/β-catenin signaling deficient embryos lacking Fgf10a function. (A-F) Hepatic sox17 expression was present in Wnt/β-catenin signaling deficient embryos treated with SU5402 (1 µM) from 30 to 44 hpf (B) as well as in Wnt/β-catenin signaling deficient embryos lacking Fgf10a function (D). Hepatic sox32 expression was also present in these embryos (F). Dorsal views, anterior to the left. (G-J) There was no clear difference in the hepatic sox17 expression domain among wild-type, fgf10a-/- and wnt2bb-/- embryos (G-I). However, it expanded into the extrahepatic duct region in most fgf10a-/-;wnt2bb-/- (J, five out of seven embryos). Dorsal views, anterior up. Scale bars, 100 µm.
Reprinted from Mechanisms of Development, 128(11-12), Shin, D., Weidinger, G., Moon, R.T., and Stainier, D.Y., Intrinsic and extrinsic modifiers of the regulative capacity of the developing liver, 525-535, Copyright (2012) with permission from Elsevier. Full text @ Mech. Dev.